Correction: Journal of Nanobiotechnology (2022) 20:546 https://doi.org/10.1186/s12951-022-01749-3
Following publication of the original article [1], the authors would like to correct the affiliations of all the authors.
The revised affiliations are provided below.
The Research and Application Center of Precision Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, China
School of Physics and Technology, Wuhan University, Wuhan 430072, China
Department of Intelligent Systems Engineering, Indiana University, Bloomington, IN 47405, USA
Division of Thoracic and Cardiac Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA
Department of Biological Sciences, Northeastern University, Boston, MA 02115, USA
The original article has been corrected.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Yanyu Chen and Zhuhao Wu contributed equally to this work
Contributor Information
Feng Guo, Email: fengguo@iu.edu.
Zi Chen, Email: zchen33@bwh.harvard.edu.
Qinqin Huang, Email: qqhuang@zzu.edu.cn.
Reference
- 1.Chen Y, Wu Z, Sutlive J, Wu K, Mao L, Nie J, Zhao X-Z, Guo F, Chen Z, Huang Q. Noninvasive prenatal diagnosis targeting fetal nucleated red blood cells. J Nanobiotechnol. 2022;20(1):546. doi: 10.1186/s12951-022-01749-3. [DOI] [PMC free article] [PubMed] [Google Scholar]